In light of these findings, we sought to expand our cohort [7] and report the clinicopathologic and genetic features of 16 cases of AML with various RUNX1 lesions, including mutations, copy number gains, and translocations, other than fusions with RUNX1T1. This evidence concerns the gene RUNX1 and acute myeloid leukemia.